Case Studies

Understanding the clinical competitive landscape

To measure its progress against other companies in its therapeutic space, a small U.S. biopharma needed to understand the biomarkers these competitors used, the endpoints established, and their likely impact on clinical trial success. In this case study, see how the company’s clinical team used Cortellis Clinical Trials IntelligenceTM to gain competitive insight that helped […]

Tapping into essential rare disease trial data

Relying on manual searches through public sources was increasingly time-consuming and insufficient, the information manager at a global rare disease specialist determined. To help her respond to the flow of requests for clinical trials information from her investigators, she needed a source of rich, trusted clinical trials data– one that had a depth of coverage […]

Competitive research tool drives targeted pipeline decisions

Quality, timely market information is fundamental to determining new product development for targets and indications. In this case study, see how a small U.K.-based company that provides research services to biopharma customers across Europe harnessed Cortellis Competitive Intelligence,TM with its accurate, comprehensive, validated, up-to-date data, to guide clients’ future drug pipeline and licensing decisions.

Targeted competitive intelligence helps MabVax determine market positioning

Could “insufficient” data be a deal killer? Over his two decades of experience, the vice president and chief business officer at MabVax had developed a profound understanding of the need for insightful, comprehensive and targeted competitive intelligence, which he found in Cortellis Competitive IntellgenceTM. See the case study.

Identifying discovery pathways opens new doors for Fiocruz

Fiocruz, the multi-dimensional Brazilian healthcare organization, not only cares for patients; it also develops vaccines, drugs, reagents and diagnostic kits. Learn in this case study how Fiocruz taps the deep, human-curated data in Metacore, a Cortellis solutionTM to help fuel its goal of becoming a major drug developer in Latin America.  

Seeing the full landscape of API manufacturing

Finding a reliable, safe supplier of API can be a challenge that holds up the process of manufacturing for generics companies large and small – delaying the release of important, affordable medications into the market. The answer, for Helm AG, was Newport, a Cortellis solution,TM which provided a complete view of the API landscape and […]

Biosidus regulatory team tracks constant global changes

Biosidus, the globally focused pharma based in Argentina, found it needed access to a single tool that would help the company stay on top of the shifts in regulations in every market in which it does business. In this case study, learn how Cortellis Regulatory Intelligence™ became a key contributor to the company’s growth strategy […]

Identifying critical licensing and M&A deal terms

The CEO of a company that focuses on business development on behalf of its biopharma customers was under pressure to help them enter the best possible deals for assets in various phases of development. In this case study, see how Cortellis Deals IntelligenceTM provided him with exactly the global data he needed, usually via unredacted […]